A Stierlé

Epinephrine potentiates human platelet activation but is not an aggregating agent

François Lanza, Alain Beretz, A Stierlé et al. · American Journal of Physiology-Heart and Circulatory Physiology · 1988 · 140 citations

Pharmacotherapy, Serotonin Secretion, Inflammation +19

A new variant of Glanzmann's thrombasthenia (Strasbourg I). Platelets with functionally defective glycoprotein IIb-IIIa complexes and a glycoprotein IIIa 214Arg----214Trp mutation.

François Lanza, A Stierlé, Dominique J. Fournier et al. · Journal of Clinical Investigation · 1992 · 120 citations · Full text

Immunology, Molecular Biology, Pathology +20

Role of cyclic AMP in the inhibition of human platelet aggregation by quercetin, a flavonoid that potentiates the effect of prostacyclin

Alain Beretz, A Stierlé, Robert Anton et al. · Biochemical Pharmacology · 1982 · 85 citations

Thrombopoiesis, Thrombosis, Medicinal Chemistry +13

The thienopyridine PCR 4099 selectively inhibits ADP-induced platelet aggregation and fibrinogen binding without modifying the membrane glycoprotein IIb–IIIa complex in rat and in man

Christian Gachet, A Stierlé, Jean‐Pierre Cazenave et al. · Biochemical Pharmacology · 1990 · 71 citations

Inflammation, Thrombosis, Molecular Pharmacology +13

Tissue and substrate specificity of inhibition by alkoxy-aryl-lactams of platelet and arterial smooth muscle cyclic nucleotide phosphodiesterases relationship to pharmacological activity

Claire Lugnier, A Stierlé, Alain Beretz et al. · Biochemical and Biophysical Research Communications · 1983 · 50 citations

Biochemistry, Blood Platelet, Medicine +8